Osteoporosis Most Recent
La Dre Alexandra Papaioannou a passé en revue les résultats d’essais de phase 3 sur le dénosumab qu’elle a décrit comme un « nouveau produit passionnant » qui fait l’objet de recherches.
Dr. Earl Bogoch’s key message concerned the importance of identifying and treating osteoporosis after a fragility fracture, in order to prevent future fractures, most importantly of the hip.
Advances in the understanding of bone biology and the role of the RANK/RANKL/OPG pathway have opened new treatment avenues for osteoporosis.
Vertebral compression fractures (VCF) are the hallmark of osteoporosis, yet two-thirds of all VCF remain undiagnosed and untreated.
Successful management of osteoporosis includes nonpharmacologic and pharmacologic strategies, aimed at fracture prevention.
MD, FRCPC, FACP, AGSF
Advertisement
MD, MSc, FRCPC, FACP, FRCPEdin